Four notes:
1. The German medical technology company will pay $16.4 billion in cash for Varian and offered $177.50 a share for its business, 24 percent more than Varian’s closing price on July 31.
2. Siemens Healthineers and Varian have collaborated for more than 10 years in areas including radiotherapy diagnostics for cancer treatments.
3. The deal will be financed through both debt and equity, and Siemens said the purchase will have a positive effect on earnings per share within the first year of the closing.
4. Varian has a market value of about $13 billion.
More articles on health IT:
4 ways wearables may detect COVID-19 in the future
Amazon’s 5 latest health-related job openings
1.1M+ health records breached in July
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
